Creo Medical Group (LON:CREO) Stock Falls 1.2% – What’s Next?

Shares of Creo Medical Group PLC (LON:CREO – Get Free Report) were down 1.2% during mid-day trading on Friday. The stock traded as low as GBX 10 and last traded at GBX 10. 519,624 shares traded hands during mid-day trading, a decline of 31% from the average daily volume of 756,295 shares. The stock had previously closed at GBX 10.12.

Analysts Set New Price Targets

Separately, Shore Capital Group reaffirmed a “house stock” rating and issued a GBX 40 target price on shares of Creo Medical Group in a research report on Thursday, July 23rd.

Check Out Our Latest Stock Report on Creo Medical Group

Creo Medical Group Trading Down 1.2%

The company has a debt-to-equity ratio of 8.09, a quick ratio of 2.19 and a current ratio of 2.79. The company has a market capitalization of £44.91 million, a P/E ratio of -2.00 and a beta of 1.56. The stock has a fifty day moving average of GBX 11.25 and a 200 day moving average of GBX 12.88.

Creo Medical Group (LON:CREO – Get Free Report) last announced its quarterly earnings data on Wednesday, September 30th. The company reported GBX (2) earnings per share (EPS) for the quarter. Creo Medical Group had a negative net margin of 268.57% and a negative return on equity of 38.29%. As a group, equities research analysts anticipate that Creo Medical Group PLC will post -10.08 EPS for the current fiscal year.

Creo Medical Group Company Profile

(Get Free Report)

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes.

Further Reading

Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.